Loading...

LNA Santé

DB:2N3
Snowflake Description

Adequate balance sheet with acceptable track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
2N3
DB
€450M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

LNA Santé SA operates and manages full-care facilities for the dependent elderly persons under the LNA Santé brand in France and Belgium. The last earnings update was 17 days ago. More info.


Add to Portfolio Compare Print
2N3 Share Price and Events
7 Day Returns
-0.9%
DB:2N3
-4.7%
DE Healthcare
1.8%
DE Market
1 Year Returns
-
DB:2N3
-21.4%
DE Healthcare
-6%
DE Market
2N3 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
LNA Santé (2N3) -0.9% -0.1% -1.2% - - -
DE Healthcare -4.7% -0.5% 12.1% -21.4% -18.6% 37.3%
DE Market 1.8% 4.2% 7.4% -6% 10.1% 15.4%
1 Year Return vs Industry and Market
  • No trading data on 2N3.
  • No trading data on 2N3.
Price Volatility
2N3
Industry
5yr Volatility vs Market

2N3 Value

 Is LNA Santé undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for LNA Santé. This is due to cash flow or dividend data being unavailable. The share price is €45.75.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for LNA Santé's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are LNA Santé's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:2N3 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in EUR €2.23
ENXTPA:LNA Share Price ** ENXTPA (2019-04-18) in EUR €46.5
Germany Healthcare Industry PE Ratio Median Figure of 10 Publicly-Listed Healthcare Companies 34.55x
Germany Market PE Ratio Median Figure of 422 Publicly-Listed Companies 19.59x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of LNA Santé.

DB:2N3 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ENXTPA:LNA Share Price ÷ EPS (both in EUR)

= 46.5 ÷ 2.23

20.88x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LNA Santé is good value based on earnings compared to the DE Healthcare industry average.
  • LNA Santé is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does LNA Santé's expected growth come at a high price?
Raw Data
DB:2N3 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 20.88x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
12.8%per year
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.31x
Germany Market PEG Ratio Median Figure of 270 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

DB:2N3 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 20.88x ÷ 12.8%

1.63x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LNA Santé is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on LNA Santé's assets?
Raw Data
DB:2N3 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in EUR €20.45
ENXTPA:LNA Share Price * ENXTPA (2019-04-18) in EUR €46.5
Germany Healthcare Industry PB Ratio Median Figure of 12 Publicly-Listed Healthcare Companies 1.5x
Germany Market PB Ratio Median Figure of 570 Publicly-Listed Companies 1.84x
DB:2N3 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ENXTPA:LNA Share Price ÷ Book Value per Share (both in EUR)

= 46.5 ÷ 20.45

2.27x

* Primary Listing of LNA Santé.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LNA Santé is overvalued based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess LNA Santé's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. LNA Santé has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

2N3 Future Performance

 How is LNA Santé expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
12.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is LNA Santé expected to grow at an attractive rate?
  • LNA Santé's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • LNA Santé's earnings growth is expected to exceed the Germany market average.
  • LNA Santé's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:2N3 Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:2N3 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts 12.8%
DB:2N3 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 6.5%
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 3.1%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 5.4%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.5%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:2N3 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:2N3 Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 738 42 1
2022-12-31 702 36 1
2021-12-31 652 67 31 1
2020-12-31 589 49 28 6
2019-12-31 533 46 22 5
DB:2N3 Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2018-12-31 539 48 22
2018-09-30 522 51 23
2018-06-30 505 53 25
2018-03-31 496 57 25
2017-12-31 487 61 24
2017-09-30 492 59 24
2017-06-30 497 58 24
2017-03-31 486 45 23
2016-12-31 475 32 22
2016-09-30 449 11 17
2016-06-30 423 -10 13
2016-03-31 424 5 12

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • LNA Santé's earnings are expected to grow by 12.8% yearly, however this is not considered high growth (20% yearly).
  • LNA Santé's revenue is expected to grow by 6.5% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:2N3 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from LNA Santé Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2N3 Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 3.16 3.16 3.16 1.00
2020-12-31 2.84 3.57 2.44 5.00
2019-12-31 2.29 2.57 2.11 5.00
DB:2N3 Past Financials Data
Date (Data in EUR Millions) EPS *
2018-12-31 2.23
2018-09-30 2.40
2018-06-30 2.57
2018-03-31 2.54
2017-12-31 2.50
2017-09-30 2.53
2017-06-30 2.56
2017-03-31 2.48
2016-12-31 2.40
2016-09-30 1.91
2016-06-30 1.42
2016-03-31 1.31

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • LNA Santé is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess LNA Santé's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
LNA Santé has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

2N3 Past Performance

  How has LNA Santé performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare LNA Santé's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • LNA Santé has delivered over 20% year on year earnings growth in the past 5 years.
  • LNA Santé's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • LNA Santé's 1-year earnings growth is negative, it can't be compared to the DE Healthcare industry average.
Earnings and Revenue History
LNA Santé's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from LNA Santé Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2N3 Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 538.76 21.53 107.66
2018-09-30 521.80 23.23 106.13
2018-06-30 504.84 24.94 104.60
2018-03-31 495.76 24.58 103.17
2017-12-31 486.67 24.22 101.73
2017-09-30 491.72 24.13 99.83
2017-06-30 496.76 24.03 97.92
2017-03-31 485.89 22.83 95.94
2016-12-31 475.02 21.62 93.96
2016-09-30 448.95 17.17 92.41
2016-06-30 422.89 12.71 90.87
2016-03-31 423.85 11.67 89.76
2015-12-31 424.82 10.62 88.65
2015-09-30 411.47 9.66 85.65
2015-06-30 398.12 8.69 82.65
2015-03-31 377.15 7.86 79.65
2014-12-31 356.17 7.03 76.66
2014-09-30 348.31 7.62 74.51
2014-06-30 340.44 8.20 72.36
2014-03-31 332.31 7.96 68.84
2013-12-31 324.17 7.72 65.32
2013-09-30 314.44 7.27 62.27
2013-06-30 304.70 6.82 59.23
2013-03-31 281.79 6.52 57.55
2012-12-31 258.88 6.23 55.86
2012-09-30 250.39 6.82 54.07
2012-06-30 241.90 7.41 52.28

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • LNA Santé has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • LNA Santé used its assets more efficiently than the DE Healthcare industry average last year based on Return on Assets.
  • LNA Santé has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess LNA Santé's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
LNA Santé has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

2N3 Health

 How is LNA Santé's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up LNA Santé's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • LNA Santé is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • LNA Santé's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of LNA Santé's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from LNA Santé Company Filings, last reported 3 months ago.

DB:2N3 Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 204.31 316.81 122.13
2018-09-30 204.31 316.81 122.13
2018-06-30 195.37 305.70 119.06
2018-03-31 195.37 305.70 119.06
2017-12-31 187.79 347.78 162.83
2017-09-30 187.79 347.78 162.83
2017-06-30 171.50 349.11 142.15
2017-03-31 171.50 349.11 142.15
2016-12-31 163.70 327.89 103.11
2016-09-30 163.70 327.89 103.11
2016-06-30 128.93 347.25 79.50
2016-03-31 128.93 347.25 79.50
2015-12-31 123.75 324.19 69.56
2015-09-30 123.75 324.19 69.56
2015-06-30 116.38 271.38 44.22
2015-03-31 116.38 271.38 44.22
2014-12-31 105.06 286.89 36.17
2014-09-30 105.06 286.89 36.17
2014-06-30 97.37 270.40 24.07
2014-03-31 97.37 270.40 24.07
2013-12-31 92.97 234.07 33.06
2013-09-30 92.97 234.07 33.06
2013-06-30 88.99 211.69 44.42
2013-03-31 88.99 211.69 44.42
2012-12-31 85.66 184.52 55.47
2012-09-30 85.66 184.52 55.47
2012-06-30 82.34 156.89 50.64
  • LNA Santé's level of debt (155.1%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (252.1% vs 155.1% today).
  • Debt is not well covered by operating cash flow (15.2%, less than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 6.6x coverage).
X
Financial health checks
We assess LNA Santé's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. LNA Santé has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

2N3 Dividends

 What is LNA Santé's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.82%
Current annual income from LNA Santé dividends. Estimated to be 1% next year.
If you bought €2,000 of LNA Santé shares you are expected to receive €16 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • LNA Santé's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1.43%).
  • LNA Santé's dividend is below the markets top 25% of dividend payers in Germany (3.72%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:2N3 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.6%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:2N3 Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2023-12-31 0.83 1.00
2022-12-31 0.67 1.00
2021-12-31 0.54 1.00
2020-12-31 0.40 5.00
2019-12-31 0.39 4.00
DB:2N3 Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2019-04-03 0.380 0.814
2018-04-26 0.320 0.640
2018-03-27 0.320 0.580
2017-04-28 0.235 0.413
2017-03-29 0.235 0.517
2016-04-28 0.160 0.485

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LNA Santé is not paying a notable dividend for Germany, therefore no need to check if the payments are stable.
  • LNA Santé is not paying a notable dividend for Germany, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of LNA Santé's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of LNA Santé's dividends as it is not paying a notable one for Germany.
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (5.9x coverage).
X
Income/ dividend checks
We assess LNA Santé's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can LNA Santé afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. LNA Santé has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

2N3 Management

 What is the CEO of LNA Santé's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jean Siret
COMPENSATION €750,000
TENURE AS CEO 26.8 years
CEO Bio

Mr. Jean paul siret has been the Chairman, Chief Executive Officer and Managing Director of le noble-age., since july 30, 1992. Mr. Siret served as the chief executive officer of sa residence de retraite francois villon. And served as 0deputy managing director of sa la chezaliere. Mr. Siret served as the president of the following companies on behalf of sa le noble age groupe: sas le noble age groupe retraite, sas la villa des collettes, sas la villa d’epidaure,sas la villa d’epidaure la celle st cloud, sas les jardins de la poterie, sas residence des sources., sas la villa amelie,sas la villa eleonore,sas la villa oceane,sas maison de la princesse elisa,sas les oiseaux,sas les mimosas,sas la villa de falicon,sas sainte anne,sas la meuliere de la marne,sas kerinou sante,sas had haute-savoie sud,sas la villa bleue,sas centre medical de arcade de fontenay sarl residence aigue marine, sarl residence harmonie, sarl les jardins de mar vivo, sarl le verger de vincennes, sarl les toits de vincennes, sarl verte prairie, sarl le parc des vignes, sarl residence creisker, sarl residence marconi, sarl le mas de la cote bleue, salr les pleiades, sarl les jardins d’olonne, sarl institut medical de romainville, sarl residence les berges du danube, sarl la villa des poetes, sarl les camelias, sarl isatis, sarl institut medical de breteuil, sarl institut medical de sologne, sarl les nympheas, sarl lna sante, sarl residence le montheard, salr le noble age groupe sante, sarl fonciere gna, sarl medica fonciere garches 92 , sarl medica fonciere d’epinay, sc financiere vertavienne 44, sarl immobiliere du vallon , sarl sibe,sarl lna services, sarl residence hotel du pays vert and sarl la capeline. He served as member of the board of directors at sa woodside residence, sa residence athena, sa residence le point du jour, groupement de cooperation sanitaire noble age groupe. He served as a member of the board of directors of the following companies on behalf of sa le noble age groupe:sa woodside residence, asbl le mont des arts, sa clinique kerlena,sa clinique les sorbiers.

CEO Compensation
  • Jean's compensation has increased by more than 20% in the past year.
  • Jean's remuneration is about average for companies of similar size in Germany.
Management Team

Jean Siret

TITLE
Chairman & CEO
COMPENSATION
€750K
TENURE
26.8 yrs

Willy Siret

TITLE
Deputy CEO & Director
COMPENSATION
€539K

Damien Billard

TITLE
Deputy Chief Executive Officer and Director
COMPENSATION
€372K

Xavier Dejardins

TITLE
Founder
Board of Directors Tenure

Average tenure of the LNA Santé board of directors in years:

11.6
Average Tenure
  • The average tenure for the LNA Santé board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Willy Siret

TITLE
Deputy CEO & Director
COMPENSATION
€539K
TENURE
13 yrs

Damien Billard

TITLE
Deputy Chief Executive Officer and Director
COMPENSATION
€372K
TENURE
10.3 yrs

Xavier Dejardins

TITLE
Founder
TENURE
26.8 yrs

Robert Dardanne

TITLE
Director
COMPENSATION
€12K
AGE
62
TENURE
26.8 yrs

Jean Siret

TITLE
Chairman & CEO
COMPENSATION
€750K
TENURE
26.8 yrs

Daniel Braud

TITLE
Director
COMPENSATION
€14K
TENURE
7.8 yrs

Patricia Rosiod

TITLE
Director
COMPENSATION
€14K

Marie Antoinette Dain

TITLE
Independent Director
TENURE
7.8 yrs

Michel Ballereau

TITLE
Non-Voting Member of The Board

Alexandre Tremblin

TITLE
Non-Voting Member of The Board
AGE
43
TENURE
8.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess LNA Santé's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. LNA Santé has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

2N3 News

Simply Wall St News

2N3 Company Info

Description

LNA Santé SA operates and manages full-care facilities for the dependent elderly persons under the LNA Santé brand in France and Belgium. The company operates nursing homes, follow-up care and rehabilitation facilities, home hospitalization structures, health centers, and psychiatric clinics. It serves patients with complex, acute, or chronic pathologies comprising neurological, respiratory, cardiovascular, psychiatric, etc. The company operates 11 clinics; 1 psychiatric clinic; and 7 home care facilities. LNA Santé SA was founded in 1990 and is based in Vertou, France.

Details
Name: LNA Santé SA
2N3
Exchange: DB
Founded: 1990
€449,994,961
9,677,311
Website: http://www.lna-sante.com
Address: LNA Santé SA
7 Boulevard Auguste Priou,
PO Box 32336,
Vertou,
Pays de la Loire, 44120,
France
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ENXTPA LNA Common Shares Euronext Paris FR EUR 07. Jun 2006
DB 2N3 Common Shares Deutsche Boerse AG DE EUR 07. Jun 2006
LSE 0OR2 Common Shares London Stock Exchange GB EUR 07. Jun 2006
BATS-CHIXE LNAP Common Shares BATS 'Chi-X Europe' GB EUR 07. Jun 2006
Number of employees
Current staff
Staff numbers
5,044
LNA Santé employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/20 22:18
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/16
Last earnings filing: 2019/04/03
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.